View in EDS HTML Full Text PDF Full Text

The Swedish open-label diflunisal trial (DFNS01) on hereditary transthyretin amyloidosis and the impact of amyloid fibril composition.

Saved in:
Bibliographic Details
Title: The Swedish open-label diflunisal trial (DFNS01) on hereditary transthyretin amyloidosis and the impact of amyloid fibril composition.
Authors: Wixner, Jonas1 (AUTHOR) jonas.wixner@umu.se, Westermark, Per2 (AUTHOR), Ihse, Elisabet2 (AUTHOR), Pilebro, Björn1 (AUTHOR), Lundgren, Hans-Erik1 (AUTHOR), Anan, Intissar1 (AUTHOR)
Source: Amyloid. 2019 Supplement 1, Vol. 26, p39-40. 2p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:13506129
DOI:10.1080/13506129.2019.1593133